Compare XTNT & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XTNT | ATLX |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.3M | 92.2M |
| IPO Year | N/A | N/A |
| Metric | XTNT | ATLX |
|---|---|---|
| Price | $0.59 | $4.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.50 | ★ $12.00 |
| AVG Volume (30 Days) | 316.0K | ★ 546.2K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $133,083,000.00 | $180,454.00 |
| Revenue This Year | $13.03 | $22,084.55 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $52.80 | ★ N/A |
| Revenue Growth | ★ 16.88 | N/A |
| 52 Week Low | $0.33 | $3.54 |
| 52 Week High | $0.95 | $8.32 |
| Indicator | XTNT | ATLX |
|---|---|---|
| Relative Strength Index (RSI) | 32.80 | 49.57 |
| Support Level | $0.61 | $4.50 |
| Resistance Level | $0.68 | $5.15 |
| Average True Range (ATR) | 0.05 | 0.48 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 10.41 | 49.35 |
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.